Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Mpox (Monkeypox): from a dermatologist's point of view].
Marchal O, Sottas C, Pastor D, Toutous Trellu L, Kaya G, Gaide O. Marchal O, et al. Among authors: gaide o. Rev Med Suisse. 2023 Mar 29;19(820):614-617. doi: 10.53738/REVMED.2023.19.820.614. Rev Med Suisse. 2023. PMID: 36988168 Review. French.
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey.
Hauschild A, Garbe C, Ascierto PA, Demidov L, Dreno B, Dummer R, Eggermont A, Forsea AM, Gebhardt C, Gershenwald JE, Hamid O, Hoeller C, Kandolf L, Kaufmann R, Kirkwood JM, Lebbé C, Long GV, Malvehy J, Martin-Algarra S, McArthur G, Neyns B, Richtig E, Robert C, Schadendorf D, Scolyer R, Sondak VK, Wainstein A, Weichenthal M, Nuti P; Melanoma World Society Study Group. Hauschild A, et al. Lancet Oncol. 2025 Jan;26(1):12-14. doi: 10.1016/S1470-2045(24)00627-2. Lancet Oncol. 2025. PMID: 39756440 No abstract available.
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.
Joo V, Abdelhamid K, Noto A, Latifyan S, Martina F, Daoudlarian D, De Micheli R, Pruijm M, Peters S, Hullin R, Gaide O, Pantaleo G, Obeid M. Joo V, et al. Among authors: gaide o. Nat Commun. 2024 Apr 30;15(1):3664. doi: 10.1038/s41467-024-47965-3. Nat Commun. 2024. PMID: 38693123 Free PMC article.
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Kinj R, Gaide O, Jeanneret-Sozzi W, Dafni U, Viguet-Carrin S, Sagittario E, Kypriotou M, Chenal J, Duclos F, Hebeisen M, Falco T, Geyer R, Gonçalves Jorge P, Moeckli R, Bourhis J. Kinj R, et al. Among authors: gaide o. Clin Transl Radiat Oncol. 2024 Feb 8;45:100743. doi: 10.1016/j.ctro.2024.100743. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2024. PMID: 38362466 Free PMC article.
EUSCAP: A Euromelanoma project to investigate skin cancer risk factors in Europe.
Wunderlich K, Suppa M, Lipski J, Deworme V, Wambreuse A, Njimi H, White J, Gaide O; Euromelanoma Working Group; Gandini S, Del Marmol V. Wunderlich K, et al. Among authors: gaide o. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e515-e517. doi: 10.1111/jdv.19710. Epub 2023 Dec 8. J Eur Acad Dermatol Venereol. 2024. PMID: 38069540 No abstract available.
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
Ramelyte E, Nägeli MC, Hunger R, Merat R, Gaide O, Navarini AA, Cozzio A, Wagner NB, Maul LV, Dummer R. Ramelyte E, et al. Among authors: gaide o. Dermatology. 2023;239(1):122-131. doi: 10.1159/000526478. Epub 2022 Sep 22. Dermatology. 2023. PMID: 36137524 Free PMC article. Review.
87 results